Erica Scalambrino

Erica Scalambrino

Auto-generated profile, based on publicly available information

Erica Scalambrino

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2023 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
ABAntonius M.H.P. van Den Besselaar
Antonius M.H.P. van Den Besselaar
ASAnne Stavelin
Anne Stavelin
SKSteve Kitchen
Steve Kitchen
MBMichelle Bryant
Michelle Bryant
ATArmando Tripodi
Armando Tripodi
CCChrista M. Cobbaert
Christa M. Cobbaert
Calibration of Prothrombin Time (PT) in terms of the International Normalized Ratio (INR) has been outlined in 'Guidelines for thromboplastins and plasmas used to control oral anticoagulant therapy' (World Health Organization, 2013). International Standard ISO 17511:2020 presents requirements for manufacturers of In-vitro Diagnostic Medical Devices (IVD MD) in documenting the calibration hierarchy for a measured quantity in human samples using a specified IVD MD. The objective of this article is to define an unequivocal, metrologically traceable calibration hierarchy for the INR measured in plasma as well as in whole blood samples. Calibration of PT and INR for IVD MD according to WHO Guidelines is similar to cases where there is a reference measurement procedure that defines the measurand for value assignment as described in ISO 17511:2020. We conclude that for PT/INR standardization the optimal calibration hierarchy includes a primary process to prepare an international reference reagent and measurement procedure that defines the measurand by a value assignment protocol conforming to clause 5.3 in ISO 17511:2020. A panel of freshly prepared human plasma samples from healthy adult individuals and patients on vitamin K antagonists is used as a commutable secondary calibrator as described in ISO 17511:2020. A sustainable metrologically traceable calibration hierarchy for INR should be based on an international protocol for value assignment with a single primary reference thromboplastin and the harmonized manual tilt tube technique for clotting time determination. The primary international reference thromboplastin reagent should be used only for calibration of successive batches of secondary reference thromboplastin reagent.

3 June 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
SASara Arcudi
Sara Arcudi
Roberta GualtierottiRoberta Gualtierotti
Roberta Gualtierotti
ESErica Scalambrino
Erica Scalambrino
MCMarigrazia Clerici
Marigrazia Clerici
SHShermarke Hassan
Shermarke Hassan
FPFlora Peyvandi
Flora Peyvandi
Emicizumab is approved for prophylaxis of patients with hemophilia A (HA). Despite its efficacy in reducing bleeding, some patients on emicizumab still experience hemarthrosis, but no tool is yet available to identify those at a higher risk of spontaneous joint bleeding. This study aimed to evaluate whether laboratory measurements (global coagulation assays and emicizumab concentration) and/or arthropathy scores can distinguish patients at higher risk of spontaneous joint bleeding while on emicizumab prophylaxis. A thrombin generation assay was performed upon the addition of tissue factor and synthetic phospholipids. Nonactivated thromboelastography was performed on citrated whole blood. Emicizumab concentrations were measured using a modified 1-stage factor VIII assay. The degree of hemophilic arthropathy was assessed using the Hemophilia Joint Health Score and Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score. A Cox proportional hazards model was used to evaluate the association between variables and bleeding. The predictive power of these variables was investigated using receiver operating characteristic (ROC) analysis. Forty patients with severe HA, with or without inhibitors, on emicizumab prophylaxis were enrolled in an observational cohort study. Ten of 40 developed spontaneous joint bleeding. None of the laboratory parameters were able to distinguish patients with a higher risk of spontaneous joint bleeding. ROC analysis showed that during emicizumab prophylaxis, only the presence of synovitis and a higher HEAD-US score were associated with spontaneous joint bleeding (area under the curve, 0.84). A greater degree of arthropathy and the presence of synovitis could help predict the risk of spontaneous joint bleeding in patients with HA on emicizumab prophylaxis.

1 May 2020 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
ABAntonius M.H.P. van Den Besselaar
Antonius M.H.P. van Den Besselaar
CRClaudia J.J. van Rijn
Claudia J.J. van Rijn
CACharmane F. Abdoel
Charmane F. Abdoel
VCVeena Chantarangkul
Veena Chantarangkul
ESErica Scalambrino
Erica Scalambrino
CCChrista M. Cobbaert
Christa M. Cobbaert
Background International Normalized Ratio (INR) is traceable to World Health Organization (WHO) International Standards for thromboplastins. International Standards must be used with a Manual Tilt Tube technique (MTT) for prothrombin time (PT) determination. An important part of the total variability of INR is due to poor harmonization of MTT across WHO reference laboratories. Objectives To determine the origins of PT differences between operators performing MTT, and to develop a harmonized MTT. Methods Two workshops were held where WHO reference laboratory operators could compare their PTs using MTT and the same equipment. A harmonized MTT was used by 7 operators in the second workshop. Results Differences have been observed in tilting frequency, and in the height of pipetting plasma in the test tube. At the beginning of the first workshop the tilting cycle time varied between 1.1 and 2.7 s. The mean PT of normal plasma obtained by pipetting plasma at the top of the tube was 14.3 s but was 12.9 s when plasma was pipetted at the bottom of the tube. When using the harmonized MTT for WHO International Standard rTF/16, the differences between operators were not greater than 1.1 s in normal plasma, and not greater than 1.3 s in patient plasma with average INR of 3.0. INR between‐operator coefficient of variation was 2.3 %. Conclusion Application of a harmonized MTT in three reference laboratories resulted in substantial reduction of between‐operator variation of PT and INR. The harmonized MTT is proposed as Candidate Reference Measurement Procedure.

19 June 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ATArmando Tripodi
Armando Tripodi
ESErica Scalambrino
Erica Scalambrino
MCMarigrazia Clerici
Marigrazia Clerici
FPFlora Peyvandi
Flora Peyvandi
The laboratory diagnosis of antiphospholipid syndrome (APS) requires the measurement of solid-phase antibodies to cardiolipin or β2-Glycoprotein-I and the search for lupus anticoagulant (LA). The diagnosis of patients whilst on anticoagulation is impaired by the difficult interpretation of results, at least for LA, owing to the fact that prolongations of clotting times induced by LA superimpose those induced by anticoagulants. This is a matter of concern as treating physicians very often need to know the APS status of their patients to make a decision on secondary antithrombotic prophylaxis. This article aims to review the effect brought about by anticoagulants on APS diagnosis and discuss the options that can be used to overcome such an effect.

10 July 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
ATArmando Tripodi
Armando Tripodi
MCMarco Capecchi
Marco Capecchi
ESErica Scalambrino
Erica Scalambrino
MCMarigrazia Clerici
Marigrazia Clerici
BSBarbara Scimeca
Barbara Scimeca
FPFlora Peyvandi
Flora Peyvandi

1 June 2020 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
ESErica Scalambrino
Erica Scalambrino
LPLidia Padovan
Lidia Padovan
VCVeena Chantarangkul
Veena Chantarangkul
MCMarigrazia Clerici
Marigrazia Clerici
AAAndrea Artoni
Andrea Artoni
ATArmando Tripodi
Armando Tripodi